251730 Introduction: Multiple myeloma (MM) is a plasma cell malignancy causing cytopenia, lytic bone lesions, and renal impairment. Diagnosis relies on CRAB criteria, serum protein electrophoresis, ...

Under the revised IMWG diagnostic criteria, a subgroup of SMM at ultra-high risk for progression has been re-classified as multiple myeloma, increasing the number of patients who require treatment ...

Smoldering multiple myeloma ... Visram A, Cook J, Warsame R. Smoldering multiple myeloma: Evolving diagnostic criteria and treatment strategies. Hematology. 2021;2021(1):673-681.

Smoldering multiple myeloma. Smoldering multiple myeloma is the pathology, but there are more monoclonal proteins than in MGUS. However, it doesn't meet the diagnostic criteria for MM because ...

Understanding the Diagnostic Criteria for Multiple Sclerosis Medically reviewed by Susan W. Lee, DO — Written by Hope Gillette on October 4, 2024 Diagnostic criteria ...

Smoldering multiple myeloma (SMM) is a precursor condition to multiple myeloma (MM). Defined in 1980 by Kyle and Greipp, 1 SMM is an asymptomatic plasma cell disorder characterized by a minimum of ...

Inclusion Criteria: - Participants must have documented multiple myeloma satisfying standard International Myeloma Working Group (IMWG) diagnostic criteria within 28 days prior to registration - ...

Multiple myeloma is the second most common haematological malignancy in high-income countries, and typically starts as asymptomatic precursor conditions—either monoclonal gammopathy of undetermined ...

Diagnosing multiple myeloma may require various tests, such as blood, urine, and imaging tests. A biopsy can help confirm a diagnosis. Staging usually follows diagnosis. Learn more here.

Multiple myeloma (MM) is a hematological malignancy characterized by unregulated and clonal proliferation of plasma cells in the bone marrow; these cells produce and secrete an anomalous monoclonal ...